The idea is to set up several programs and let the consumer choose, … But the problem is that a competitive model isn’t good for everyone.

Under this plan, the state will end up folding its own programs, such as Medicaid, into the federal one, … That means they’ll be charged for Medicaid costs anyway. The state may end up paying...

This plan works for those on the lowest end of the income spread, … But for most people, the way it’s set up, the insurance companies and pharmaceutical companies are going to make a killing.

Maybe this is one way to move the federal government. It’s a ridiculous way to be addressing the problem to go state by state, receiving threats from the government saying it’s illegal, and yet states...

This is going to add fuel to the fire in terms of states’ frustration with the federal government.

Ultimately, we do have to fix the whole health care system in this country. But we don’t have to wait for that to happen to get drug prices under control. We can do that now...

And the incentives are completely wrong. It makes no sense to have multiple programs, and there is no provision for negotiating prices with the companies. Anyone who looked at the law as it was being...

On a drug-by-drug basis, someone could save well over $1,000 a year. For someone who is not covered by the soon-to-be-rolled out Medicare program and isn’t elderly and doesn’t have any coverage, $1,000 is huge....

The overall trend for many years now is that drug prices go up substantially more than the rate of inflation, and that continues to be the case. Even though it’s up less than in the...

Drugs are overpriced in general, and because we are one of the only countries that truly does not negotiate or set prices, our consumers are paying the price.

Unless we take significant steps to address that, it’s going to continue to be the problem. States have attempted to address this, but are somewhat constrained in what they’re allowed to do. It raises the...